Capecitabine
NDC 82511-002, capecitabine, tablet, film coated, from Teyro Labs Private Limited.
- Product NDC
- 82511-002
- Status
- Listed
- Labeler
- Teyro Labs Private Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217237
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82511-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CAPECITABINE500 mg/1
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82511-002-50 | 82511000250 | 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82511-002-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0c873e5b-51c2-4685-86c5-53f98563b093
Use it
Look up 82511-002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82511-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82511-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.